How patient advocates can engage with CMS
On Day 2 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit, a panel titled Implementing Legislation—Engaging CMS dug into the importance …
On Day 2 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit, a panel titled Implementing Legislation—Engaging CMS dug into the importance …
Every member of the Council of State Bioscience Associations (CSBA) signed a letter to President Biden expressing serious concerns with the proposed expansion of a …
Expanding WTO IP waiver would hurt SMEs, CSBA tells Biden Read More »
With the midterm elections less than two weeks away, and a new Congress beginning in just about two months, lobbying and educating Members of …
A new Congress is coming. How can patient advocates engage effectively? Read More »
Echoing a bipartisan Senate letter last week, two top House trade leaders are raising serious concerns about the proposed expansion of the World Trade Organization (WTO) …
House leaders speak out on COVID IP waiver expansion Read More »
The Advisory Committee on Immunization Practices (ACIP), the CDC’s panel of independent vaccination advisers, yesterday recommended adding COVID-19 vaccines to the list of recommended …
CDC committee recommends adding COVID vaccines to routine immunization schedules Read More »
In a significant bipartisan statement, eight senators this week sent a letter to U.S. Trade Representative Katherine Tai to express their concerns about a …
Letter from bipartisan group of senators expresses concerns over WTO IP waiver Read More »
With the goal of managing “the risk of biological incidents, whether naturally occurring, accidental, or deliberate,” President Biden Tuesday signed National Security Memorandum-15 (NSM-15) …
Biden releases Biodefense Strategy, involving biotech in national defense Read More »
When the U.S. Department of Health and Human Services (HHS) follows the president’s instructions to find ways to reduce the cost of prescription drugs, …
BIO experts say tackling PBMs would help reduce drug prices Read More »
Health and Human Services (HHS) Secretary Xavier Becerra is reportedly open to the idea of using the “march-in” provision of the Bayh-Dole Act to …
HHS says march-in rights for drug price controls ‘not off the table’ Read More »
Vir Biotechnology Inc. has won a multi-year agreement with the U.S. government to support pandemic preparedness for influenza and other infectious disease threats, the …
Vir Biotechnology gets government funding to address flu and future pandemics Read More »